Tirzepatide targets multiple pathways involved in appetite regulation and glucose metabolism, leading to reduced food intake, weight loss, and improved glycemic control
Agonism of GPR119 in both healthy or diabetic and obese mice, is known to improve glucose tolerance (90), or even prevent atherosclerosis in mice (332), while at the same time inducing the secretion of glucagon under low glucose levels avoiding hypoglycaemia (91)
Sankaranarayanapillai M, Zhang N, Baggerly KA, Gelovani JG
PLoS ONE 12 , e0178525 (2017)
The 2 non-canonical amino acids (Aib*) in tirzapetide, versus the 1 in semaglutide, makes it more difficult to recombinantly express
A comprehensive genome-wide profiling comparison between HBV and HCV infected hepatocellular carcinoma